What's in Aclaris Therapeutics, Inc.'s pipeline?

Aclaris Therapeutics, Inc. has 14 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 9 in Phase 2, 3 in Phase 1.

Which companies overlap with Aclaris Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: AbbVie, AbbVie Inc., Astellas Pharma Global Development, Inc., Ain Shams University, Appello Pharmaceuticals, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/aclaris-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Aclaris Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Aclaris Therapeutics, Inc. pipeline: 1 marketed, 0 filed, 1 Phase 3, 9 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 9 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
A-101 Topical Solution	A-101 Topical Solution	marketed
A-101 Solution	A-101 Solution	phase 3	Topical cytolytic agent		Dermatology

Therapeutic area mix

Dermatology · 5
Immunology · 2
Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 2 shared drug classes
AbbVie Inc. · 1 shared drug class
Astellas Pharma Global Development, Inc. · 1 shared drug class
Ain Shams University · 1 shared drug class
Appello Pharmaceuticals, Inc. · 1 shared drug class
Arcutis Biotherapeutics, Inc. · 1 shared drug class
Addpharma Inc. · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Aclaris Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Aclaris Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/aclaris-therapeutics-inc. Accessed 2026-05-16.